- Home
- QNRX vs HODO Comparison
QNRX vs HODO Comparison
Compare QNRX & HODO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.02
HOLD
Current Price
$0.07
Company Overview
Basic Information| Metric | QNRX | HODO |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 10.3M |
| IPO Year | 2023 | 2024 |
Fundamental Metrics
Financial Performance| Metric | QNRX | HODO |
|---|---|---|
| Price | $4.02 | $0.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $20.71 | N/A |
| AVG Volume (30 Days) | 36.0K | ★ 16.8M |
| Earning Date | 11-05-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $105.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.37 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.25 | $0.05 |
| 52 Week High | $23.50 | $2.52 |
Technical Indicators
Market Signals| Indicator | QNRX | HODO |
|---|---|---|
| Relative Strength Index (RSI) | 30.65 | 20.95 |
| Support Level | $3.25 | $0.05 |
| Resistance Level | $5.18 | $0.20 |
| Average True Range (ATR) | 0.36 | 0.02 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 9.09 | 18.19 |
Price Performance
Historical Comparison QNRX
HODO
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.